1. Kawasaki T, Kosaki F, Okawa S, et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54(3):271-276.

2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110(17):2747-2771.

3. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J 2005; 24 (5):429-433.

4. Burns JC, Cayan DR, Tong G, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology 2005; 16(2):220-225.

5. Bronstein DE, Dille AN, Austin JP, et al. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J 2000; 19 (11):1087—1091.

6. Holman RC, Shahriari A, Effler PV, et al. Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut. Arch Pediatr Adolesc Med 2000; 154(8):804-808.

7. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003; 112(3):495-501.

8. Burns JC, Shimizu C, Shike H, et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 2005; 6(5):438-444.

9. Burns JC, Shimizu C, Gonzalez E, et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 2005; 192 (2):344-349.

10. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991; 119(2):279-282.

11. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364(9433):533-544.

12. Burns JC, Felsburg PJ, Wilson H, et al. Canine pain syndrome is a model for the study of Kawasaki disease. Perspect Biol Med 1991; 35(1):68-73.

13. Naoe S, Takahashi K, Masuda H, et al. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 1991; 41(11):785-797.

14. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: I. pathology and morphogenesis of the vascular changes. Jpn Circ J 1979; 43(7):633-643.

15. Brown TJ, Crawford SE, Cornwall ML, et al. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001; 184(7):940-943.

16. Burns JC, Shike H, Gordon JB, et al. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28(1):253-257.

17. Rowley AH, Shulman ST, Spike BT, et al. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001; 166(2):1334-1343.

18. Rowley AH, Shulman ST, Mask CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000; 182(4): 1183-1191.

19. Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis 2004; 190(4): 856-865.

20. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16(3):178-222.

21. Shike H, Burns JC, Shimizu C. Translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J 2002; 21(11):online, http//

22. Corbeel L, Delmotte B, Standaert L, et al. Kawasaki disease in Europe. Lancet 1977; 1(8015): 797-798.

23. Giesker DW, Pastuszak WT, Forouhar FA, et al. Lymph node biopsy for early diagnosis in Kawasaki disease. Am J Surg Pathol 1982; 6(6):493-501.

24. Smith LB, Newburger JW, Burns JC. Kawasaki syndrome and the eye. Pediatr Infect Dis J 1989; 8 (2):116-118.

25. Burns JC, Wright JD, Newburger JW, et al. Conjunctival biopsy in patients with Kawasaki disease. Pediatr Pathol Lab Med 1995; 15(4):547-553.

26. Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics ofpatients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991; 118(5):680-686.

27. Sato N, Sagawa K, Sasaguri Y, et al. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J Pediatr 1993; 122(2):198-203.

28. Kimura T, Miyazawa H, Watanabe K, et al. Small pustules in Kawasaki disease. A clinicopathological study of four patients. Am J Dermatopathol 1988; 10(3):218-223.

29. Friter BS, Lucky AW. The perineal eruption of Kawasaki syndrome. Arch Dermatol 1988; 124(12):1805-1810.

30. April MM, Burns JC, Newburger JW, et al. Kawasaki disease and cervical adenopathy. Arch Otolaryngol Head Neck Surg 1989; 115(4):512-514.

31. Park AH, Batchra N, Rowley A, et al. Patterns of Kawasaki syndrome presentation. Int J Pediatr Otorhinolaryngol 1997; 40(1):41-50.

32. Kryzer TC, Derkay CS. Kawasaki disease: five-year experience at Children's National Medical Center. Int J Pediatr Otorhinolaryngol 1992; 23(3):211-220.

33. Seicshnaydre MA, Frable MA. Kawasaki disease: early presentation to the otolaryngologist. Otolaryngol Head Neck Surg 1993; 108(4):344-347.

34. Murrant NJ, Cook JA, Murch SH. Acute ENT admission in Kawasaki disease. J Laryngol Otol 1990; 104(7):581-584.

35. Kao HT, Huang YC, Lin TY. Kawasaki disease presenting as cervical lymphadenitis or deep neck infection. Otolaryngol Head Neck Surg 2001; 124(4):468-470.

36. Waggoner-Fountain LA, Hayden GF, Hendley JO. Kawasaki syndrome masquerading as bacterial lymphadenitis. Clin Pediatr (Phila) 1995; 34(4):185-189.

37. Puczynski MS, Stankiewicz JA, Ow PE. Mucocutaneous lymph node syndrome mimicking acute coalescent mastoiditis. Am J Otol 1986; 7(1):71-73.

38. McLaughlin RB Jr, Keller JL, Wetmore RF, et al. Kawasaki disease: a diagnostic dilemma. Am J Otolaryngol 1998; 19(4):274-277.

39. Shetty AK, Homsi O, Ward K, et al. Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: success with pulse steroid therapy. J Rheumatol 1998; 25(6):1215-1217.

40. Rothfield RE, Arriaga MA, Felder H. Peritonsillar abscess in Kawasaki disease. Int J Pediatr Otorhinolaryngol 1990; 20(1):73-79.

41. Hester TO, Harris JP, Kenny JF, et al. Retropharyngeal cellulitis: a manifestation of Kawasaki disease in children. Otolaryngol Head Neck Surg 1993; 109(6):1030-1033.

42. Burgner D, Festa M, Isaacs D. Delayed diagnosis of Kawasaki disease presenting with massive lymphadenopathy and airway obstruction. Br Med J 1996; 312(7044):1471-1472.

43. Homicz MR, Carvalho D, Kearns DB, et al. An atypical presentation of Kawasaki disease resembling a retropharyngeal abscess. Int J Pediatr Otorhinolaryngol 2000; 54(1):45-49.

44. Bradley MK, Crowder TH. Retropharyngeal mass in a child with mucocutaneous lymph node syndrome. Clin Pediatr (Phila) 1983; 22(6):444-445.

45. Korkis JA, Stillwater LB. An unusual otolaryngological problem—mucocutaneous lymph node syndrome (Kawasaki's syndrome) case report. J Otolaryngol 1985; 14(4):257-260.

46. Dengler LD, Capparelli EV, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J 1998; 17(6):478-481.

47. Ting EC, Capparelli EV, Billman GF, et al. Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease. Pediatr Infect Dis J 1998; 17(5):431-432.

48. Sundel RP, Newburger JW, McGill T, et al. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr 1990; 117(3):371-377.

49. Sundel RP, Cleveland SS, Beiser AS, et al. Audiologic profiles of children with Kawasaki disease. Am J Otol 1992; 13(6):512-515.

50. Knott PD, Orloff LA, Harris JP. Sensorineural hearing loss and Kawasaki disease: a prospective study. Am J Otolaryngol 2001; 22(5):343-348.

51. Tashiro N, Matsubara T, Uchida M, et al. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics 2002; 109(5):E77.

52. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324 (23):1633-1639.

53. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000; 290(5489):84-89.

54. Ruiz de Souza V, Carreno MP, Kaveri SV, et al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 1995; 25(5):1267-1273.

55. Burns JC, Capparelli EV, Brown JA, et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998; 17 (12):1144—1148.

56. Sundel RP, Burns JC, Baker A, et al. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993; 123(4):657-659.

57. Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128(1):146-149.

58. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005; 146(5):662-667.

59. Newburger JW, Burns JC. Kawasaki disease. Vasc Med 1999; 4(3):187-202.

60. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94(6):1379-1385.

Part B & Infectious Diseases

Hearing Aids Inside Out

Hearing Aids Inside Out

Have you recently experienced hearing loss? Most probably you need hearing aids, but don't know much about them. To learn everything you need to know about hearing aids, read the eBook, Hearing Aids Inside Out. The book comprises 113 pages of excellent content utterly free of technical jargon, written in simple language, and in a flowing style that can easily be read and understood by all.

Get My Free Ebook

Post a comment